Invasive micropapillary serous carcinoma (MPSC) also designated ''low-grade serous carcinoma'' (LGSC) of the ovary is characterized by small micropapillae that infiltrate underlying tissue (ovarian stroma). On occasion these tumors in addition to the micropapillae contain large macropapillae lined by bland epithelium. In rare cases, the entire tumor is composed of macropapillae. In these cases, the question of whether this is an invasive carcinoma or an unusual type of adenofibroma has been raised. The goal of this study was to describe this unusual macropapillary pattern of invasion in LGSC. Cases of LGSC containing macropapillae were retrieved from the files of the Johns Hopkins Hospital. In addition to a detailed morphologic analysis, the mutational status of KRAS and BRAF in the macropapillary, noninvasive, and invasive MPSC components was analyzed by nucleotide sequencing. There were 14 cases containing macropapillae (11 cases of LGSC, 2 cases of atypical proliferative serous tumor (APST) with microinvasion, and 1 case of APST with a focus of LGSC with macropapillae in perivaginal soft tissue). In 3 cases, extraovarian metastases contained macropapillae. Molecular analysis of the primary tumor components (macropapillary, noninvasive, and invasive MPSC and/or APST) was performed in 7 cases and of a lymph node metastasis with macropapillae in 1 case. The identical KRAS mutation was detected in all of the analyzed components of the primary ovarian tumors in 4 cases. In one of these cases, macropapillae in the lymph node metastasis contained a KRAS mutation identical to the primary tumor. The BRAF mutation identified in 1 case was identical in all components of the ovarian tumor. The identical mutations in the macropapillae and the other tumor components in each case indicate that they are clonally related. The finding of macropapillae within lymph nodes supports the interpretation that the macropapillary component is another manifestation of invasion in LGSC. The recognition of this pattern is important, especially in cases when a tumor is composed entirely of macropapillae.
M icropapillary serous carcinoma (MPSC) was described in 1996 as a variant of a noninvasive serous tumor. 4 It has also been reported as ''serous borderline tumor (SBT), micropapillary type.'' Subsequently, MPSCs were further subdivided into noninvasive and invasive types. 26 The invasive MPSC is the most common histologic type of low-grade serous carcinoma (LGSC).
The controversy in the nomenclature of low-grade serous tumors of the ovary was addressed at The Borderline Ovarian Tumor Workshop, Bethesda, MD, 2003. 2 It was concluded that the terms ''borderline tumor,'' ''tumor of low malignant potential,'' and ''atypical proliferative serous tumor'' are equivalent. In this report, we use the term ''atypical proliferative serous tumor'' (APST) and noninvasive MPSC for SBTs with a micropapillary pattern.
Several studies suggest that noninvasive tumors with a micropapillary pattern are low-grade carcinomas. 4, 17, 26 Recently presented preliminary data from a large long-term follow-up study from M.D. Anderson Cancer Center comparing APST and noninvasive MPSC to invasive MPSC demonstrated that when the micropapillary component of a noninvasive tumor involves >10% of the neoplasm, the behavior is the same as that of invasive LGSC. 13 Molecular genetic studies have reported that lowgrade serous carcinomas and as well as atypical proliferative serous tumors and noninvasive MPSCs have KRAS or BRAF mutations in about two-thirds of the cases and only rarely contain TP53 mutations. 12, 14, 18, [20] [21] [22] [23] [24] In contrast high-grade serous carcinomas have TP53 mutations in over 80% of cases, but lack KRAS and BRAF mutations. 22, 24, 25 On the basis of these findings a dualistic model of ovarian carcinogenesis has been proposed. In this model, APSTs and noninvasive MPSCs (SBT, micropapillary type) are precursors of invasive LGSCs (invasive MPSCs). 18, 19 In contrast, the precursor of high-grade serous carcinoma is not well characterized and therefore has been described as arising de novo, 1, 15 however, recent data suggest that high-grade serous carcinomas arise from intraepithelial carcinomas within ovarian inclusion cysts or fallopian tube epithelium. [5] [6] [7] [8] 10, 11 Most of the LGSCs display a micropapillary pattern, but some occasionally contain large, ''macro'' papillae, distributed in a haphazard infiltrative pattern. 9, 16 The current study is a clinicopathologic and molecular genetic analysis aimed at characterizing this uncommon pattern of invasion in LGSC and evaluating the relationship of macropapillae to coexistent APST and/or noninvasive and invasive MPSC.
MATERIALS AND METHODS
This study was approved by the Office of Human Subject Research Institutional Review Board of the Johns Hopkins University School of Medicine.
Case Selection
Cases of LGSC and APST containing macropapillae were retrieved from the files of the Department of Pathology of the Johns Hopkins Hospital. These macropapillae are distinctly different from the typical micropapillae of LGSC that contain minimal or no identifiable stroma. They contain more abundant stroma composed of spindle cells. A ''macropapilla'' was defined as a papillary structure within the invasive component of the tumor, measuring at least 0.3 mm in greatest dimension ( Fig. 1D ). Occasionally, the stromal core would be absent, probably due to the fact that the psammoma body occupying the core had fallen out during processing, creating this artifact and giving the papillae an ''empty'' appearance. These ''empty'' papillae are invariably present along with the ones that have an identifiable stromal core. The stromal core is covered by low-grade epithelium exhibiting serous differentiation with or without ciliated cells. They are present in the ovarian stroma (or extraovarian sites) in haphazard infiltrative distribution and always at least partially surrounded by a cleftlike space. In this study, the smallest percentage of macropapillae observed within the primary tumor was 20%. An arbitrary cut off of 10% can be considered when diagnosing a tumor as having macropapillary features.
Patient age, tumor size, and laterality data were obtained from the surgical pathology reports. All the cases were reviewed by 2 authors (A.Y. and R.J.K.). The presence of macropapillae and micropapillae was recorded, and the percentage of macropapillae estimated. The number of slides of the ovarian tumors ranged from 3 to 24 slides (median/mean 13/12.5 slides). Evidence of extraovarian disease was noted including noninvasive implants and foci of metastatic LGSC (invasive implants) with particular attention to the presence of a macropapillary pattern.
Molecular Genetic Analysis
Paraffin blocks from 8 cases were available for molecular analysis. These included cases 1 to 6, 11, and 12 (case numbers refer to the case list in Table 1 ). Sections (10 mm) were mounted on the membrane Palm slides and stained with hematoxylin and eosin. The epithelium lining of macropapillae was harvested using laser capture microdissection under an inverted microscope by a surgical pathologist (AY). Other components of the ovarian tumors and extraovarian metastases were also obtained by scraping tissue from the corresponding areas of the slide. Genomic DNA was isolated by using a PicoPure DNA extraction kit (Arcturus, Mountain View, CA). The DNA from the tissue obtained by scraping of the tumor areas from the slides was extracted using overnight digestion with proteinase K at 651C and subsequent heat inactivation of the enzyme at 951C for 30 minutes or Agencourt FormaPure Kit (Beckman Coulter). Primers used for polymerase chain reaction amplification were: KRAS-forward 5 0 TAAGGCCTG CTGAAAATGACTG 3 0 , reverse 5 0 -TGGTCCTGCAC CAGTAATATGC-3 0 ; BRAF forward 5 0 -TGCTTGCTC TGATAGGAAAATGA-3 0 , reverse 5 0 -CCACAAATTG GATCCAGACAAC-3 0 . Polymerase chain reaction products were obtained from 7 cases (cases 1, 3, 4, 5, 6, 11, and 12) ( Table 2 ). Mutational analysis was performed by nucleotide sequencing at the Core Facility of the Johns Hopkins Medical Institution.
RESULTS
The clinicopathologic features of the ovarian tumors are summarized in Table 1 .
There were 11 cases of low-grade serous carcinoma (invasive MPSC) with macropapillary invasive component ( Fig. 1 ) and 3 cases of an atypical proliferative serous tumor with a macropapillary component. Of the latter 3 cases, 2 contained microscopic invasive foci with macropapillae, measuring less than 5 mm in greatest dimension (cases 9 and 14); in one case there were bilateral APSTs without invasion, but a focus of tumor demonstrating a purely macropapillary pattern, identical to those in the ovary in the other cases, was found in perivaginal soft tissue (case 13).
The mean and median sizes of the ovarian tumors were 12.2 and 11.8 cm respectively (range: 5.5 to 27.0 cm). The ovarian tumors were bilateral in 10 cases and unilateral in 4. The noninvasive component was APST alone in 6 cases. Five cases had APST and noninvasive MPSC and 1 case contained noninvasive MPSC without APST. In 2 cases, the ovarian tumors were composed entirely of pure invasive LGSC (cases 4 and 12). In 3 cases (cases 2, 9, and 13) the macropapillary component was the only invasive component present (Fig. 2) . One of these (case 9) contained microscopic invasive foci in an APST, largest measuring 3 mm in greatest dimension. In one case of bilateral APSTs, a focus of tumor in perivaginal soft tissue was composed entirely of macropapillae (case 13). The macropapillary component was present in both ovaries in 6 of 10 bilateral tumors. One of these (case 6) contained a microscopic invasive focus, measuring 4 mm in greatest dimension in one of the ovaries (Fig. 3) . The mean/median percent of the macropapillary component was 63%/60% (range: 20% to 100%). In 2 of 8 cases that were thoroughly staged, the tumor was confined to the ovaries. Six cases were Fe´de´ration Internationale de Gyne´cologie et d'Obste´trique stage III. Extraovarian disease included noninvasive implants in 2 cases, foci of invasive carcinoma in the peritoneum and omentum in 6 cases (invasive implants), and lymph node metastasis in 3 cases. The extraovarian foci contained macropapillae in 3 cases, including 1 case (case 1) with lymph node metastasis, in which the tumor replaced the lymph node parenchyma, 1 case (case 7) in the omentum (Fig. 4) , and 1 in perivaginal soft tissue (case 13). Only the latter (case 13) was composed entirely of macropapillae. The first 2 cases contained a mixture of macropapillae and micropapillae in metastatic foci.
Molecular analysis was performed in 7 cases ( Table  2 ). In 4 cases, both macropapillary and micropapillary components (noninvasive and invasive) contained an identical KRAS mutation, in each case. In one of these cases (case 1), the KRAS mutation identical to the ovarian tumor components was present in the macropapillae in the lymph node metastasis. An identical BRAF mutation was found in the APST, macropapillary, and invasive micropapillary components in 1 tumor. Two tumors contained wild-type KRAS and BRAF.
DISCUSSION
The morphologic and molecular genetic findings in this study indicate that macropapillae arranged in a haphazard infiltrative pattern are a manifestation of invasion in low-grade serous carcinomas. Usually, the macropapillae are intimately admixed with micropapillae. Tumors composed entirely of macropapillae are rare, but important because the minimal cytologic atypia and low mitotic index can lead to a benign interpretation. It would have been of interest to analyze the behavior of tumors composed solely of macropapillae but, they are extremely rare, and we were unable to collect a sufficient number of cases to determine their biologic behavior.
The tumors in this study demonstrate a spectrum of morphologic findings similar to those described in MPSC, including the presence of microscopic foci of invasion that measure less than 5 mm, frankly invasive carcinoma, and extraovarian metastases. 3, 4, 26 Macropapillary serous carcinoma generally is associated with its putative precursor lesion APST and noninvasive MPSC. In one case of bilateral ovarian APSTs, a focus of invasive macropapillary serous carcinoma was found in perivaginal soft tissue. The relationship of this focus to the ovarian neoplasm is not entirely clear. Although the ovarian tumor was adequately sampled (14 sections from a 10 cm tumor), it is still possible that a focus of invasive carcinoma was present in the unsampled areas and therefore the perivaginal lesion could represent a metastasis from the ovary.
In one case, the ovarian tumor was composed entirely of macropapillae whereas the metastasis in the lymph nodes and omentum were composed of typical MPCS without macropapillae. There are 3 possible explanations for this discordant finding. First, this could simply represent variation in the morphologic manifestation of the same clonal process. Second, inadequate sampling of the ovarian tumor may have failed to detect a micropapillary component. Third, the ovarian and peritoneal tumors may have been independent primaries. Unfortunately, we were unable to perform molecular analysis to confirm either of these possibilities.
The presence of an identical KRAS or BRAF mutation in the noninvasive components in addition to the invasive micropapillary and macropapillary components indicates that they share a common lineage. Mutations that were found in tumors containing macropapillae involved the same loci (KRAS-codon 12, and BRAF-codon 600) that have been previously described in APSTs and MPSCs. 20, [22] [23] [24] Tumors containing macropapillae were found in extraovarian sites, specifically lymph nodes and omentum. In one case, the macropapillae in a lymph node contained the identical mutation as the primary tumor indicating that this was indeed a metastasis from the ovarian neoplasm. Macropapillae are more often observed in combination with invasive MPSC within the ovary and extraovarian metastases, but occasionally it is the only pattern of invasion. When this occurs, these neoplasms can be potentially misinterpreted as a serous adenofibroma. 
